NovaSignal was founded in 2013 with the sole mission of providing greater access to critical data needed by physicians to improve the lives of their patients. Co-Founder Dr. Robert Hamilton was pursuing his Ph.D. in the Department of Neurosurgery at UCLA and it was here that he developed NovaSignal’s core technology that is in use by physicians across the world today.
Robert worked daily in the neurocritical care unit, and conducted international research in Haiti, China, and Malawi where access to medical technology was limited. It was these combined experiences that inspired him to start NovaSignal, and after he was introduced to MBA students Dan Hanchey and Leo Petrossian the NovaSignal story began!
Systems in use in the US and Europe
Grants awarded by the National Institutes of Health, National Science Foundation, and Department of Defense
Received regulatory clearance on two medical devices
The idea for NovaSignal started in a village in Malawi, where co-founder Robert Hamilton was using transcranial doppler ultrasound to help diagnose pediatric malaria. NovaSignal systems are used in cerebral malaria clinics in Malawi, Zambia, Nigeria, and the Democratic Republic of Congo (DRC).
NovaSignal recently donated eight Lucid™ TCD systems to help Nationwide Children’s Hospital develop malaria and sickle cell centers of excellence throughout sub-Saharan Africa.